RoddyMedical Selected for Mayo Clinic & ASU MedTech Accelerator Program
Company Meets with Top Experts and Brings Home Audience Choice Award
Stay updated with breaking news from Scare Med. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Company Meets with Top Experts and Brings Home Audience Choice Award
· Established market leader in stroke AI imaging receives its first FDA clearance in the lung imaging space.· With this expanded foundation of AI-driven healthcare solutions, the Oxford-based company remains committed t...
The field of sleep medicine can improve ICU patients' outcomes. But first, we need progress on at least three key fronts.
Severe influenza A virus (IAV) infections can result in hyper-inflammation, lung injury and acute respiratory distress syndrome1–5 (ARDS), for which there are no effective pharmacological therapies. Necroptosis is an attractive entry point for therapeutic intervention in ARDS and related inflammatory conditions because it drives pathogenic lung inflammation and lethality during severe IAV infection6–8 and can potentially be targeted by receptor interacting protein kinase 3 (RIPK3) inhibitors. Here we show that a newly developed RIPK3 inhibitor, UH15-38, potently and selectively blo...
In this article, we hear how Sepsis Canada is working to promote sepsis awareness through supporting research and public education